Pharmacological and ablative hybrid therapy of atrial fibrillation: Long-term effect on quality of life and arrhythmia-related symptoms

Zeitschrift fur Kardiologie

Volumn 94, Issue 9, 2005, Pages 564-569

  Bielik, H ^a   Schrickel, J ^a   Shlevkov, N ^a   Yang, A ^a   Schwab, J O ^a   Bitzen, A ^a   Luderitz B ^a   Lewalter, T ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Atrial fibrillation; Catheter ablation; Hybrid therapy; Quality of life

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; FLECAINIDE; PROPAFENONE;

ADULT; AGED; ARTICLE; CATHETER ABLATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HUMAN; MALE; PATIENT MONITORING; QUALITY OF LIFE; QUESTIONNAIRE; RECURRENT DISEASE; SHORT FORM 36;

ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CATHETER ABLATION; COMBINED MODALITY THERAPY; FEMALE; GERMANY; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PATIENT SATISFACTION; PROGNOSIS; QUALITY OF LIFE; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 24644448832     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00392-005-0263-9     Document Type: Article

References (24)

1. Anselme F, Saoudi N, Poty H, Douillet R, Cribier A (1999) Radiofrequency catheter ablation of common atrial flutter significance of palpitation and quality-of-life evaluation in patients with proven Isthmus block. Circulation 99:543-540
2. Bubien RS, Knotts-Dolson SM, Plumb VJ, Kay GN (1996) Effect of Radiofrequency catheter ablation on health-related quality of life and activities of daily living in patients with recurrent arrhythmias. Circulation 94:1585-1591
3. Cheng TO (1956) Atrial flutter during quinidine therapy of atrial fibrillation. Am Heart J 52:273-289
4. Cosio FG, Lopez M, Gociolea A, Arribas F, Barroso JL (1993) Radiofrequency ablation of the inferior vena cava-tricuspid valve isthmus in common atrial flutter. Am J Cardiol 71:705-709
5. Dorian P, Jung W, Newman M, Wood K, Ayers GM, Camm J, Akhtar M, Lüderitz B (2000) The impairment of health-related quality of life in patient with intermittent atrial fibrillation. Implications for the assessment of investigational therapy. J Am Coll Cardiol 36:1303-1309
6. Ehrlich JR, Hohnloser SH (2005) Pharmacological cardioversion of atrial fibrillation Z Kardiol 94:14-22
7. Hlatky MA, Vaughn WK (1996) Quality of life in patients with supraventricular arrhythmia. Circulation 94: 1491-1493
8. Huang DT, Monahan KM, Zimetbaum P, Papageorgion P, Epstein LM, Josephson ME (1998) Hybrid pharmacologic and ablative therapy: a novel and effective approach for the management of atrial fibrillation. J Cardiovasc Electrophysiol 9:462-469
9. Jung W, Herwig S, Camm AJ, Dorian P, Newman D, Akhtar M, Wood K, Ayers GM, Lüderitz B (1998) Impact of atrial fibrillation on quality of life: a prospective, multicenter study (Abstr). Pacing Clin Electrophysiol 21 (Par II): 981
10. Mc Horney CA, Ware JE, Raczek AE (1993) The MOS 36-Item Short-Form Heath Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Car 31:247-263
11. Nabar A, Rodriguez LM, Timmermans C, Mechelen R, Wellens HJ (2001) Class IC antiarrhythmic drug induced atrial flutter: electrocardiographic and electrophysiological findings and their importance for long-term outcome after right atrial isthmus ablation. Heart 85:424-429
12. Nabar A, Rodriguez LM, Timmermans C, Smeets JL, Wellens HJ (1999) Radiofrequency ablation of "class IC atrial flutter" in patients with resistant atrial fibrillation. Am J Cardiol 83:785-787
13. Reithmann C, Hoffmann E, Spitzberger G, Dorwarth U, Gerth A, Remp T, Steinbeck G (2000) Catheter ablation of atrial flutter due to amiodarone therapy for paroxysmal atrial fibrillation. Eur Heart J 21:565-572
14. Riva S, Tondo C, Carbucicchio C, Galimberti P, Fassini G, Della Bella P (1999) Incidence and clinical significance of transformation of atrial fibrillation to atrial flutter in patients undergoing long-term antiarrhythmic drug treatment. Europace 1:242-247
15. Roithinger F, Karch MR, Steiner PR, SippensGroenewegen A, Lesh MD (1997) Relationship between atrial fibrillation and typical atrial flutter in humans: activation sequence during spontaneous conversion. Circulation 18:3484-3491
16. Savelieva I, Paquette M, Dorian P, Lüderitz B, Camm J (2001) Quality of life in patients with silent atrial fibrillation. Heart 85:216-217
17. Schrickel J, Bielik H, Yang A, Schwab JO, Shlevkov N, Schimpf R, Luderitz B, Lewalter T (2003) Amiodarone-associated "torsade de pointes". Relevance of concomitant cardiovascular medication in a patient with atrial fibrillation and structural heart disease. Z Kardiol 92:889-892
18. Schumacher B, Jung W, Lewalter T, Vahlhaus C, Wolpert C, Lüderitz B (1999) Radiofrequency ablation of atrial flutter due to administration of class IC antiarrythmic drugs for atrial fibrillation. Am J Cardiol 83: 710-713
19. Schumacher B, Lewalter T, Wolpert C, Jung W, Lüderitz B (1998) Radiofrequency catheter ablation of atrial flutter. J Cardiovasc Electrophysiol 9:139-146
20. Schumacher M, Olschewski M, Schulgen G (1991) Assessment of quality of life in clinical trials. Stat Med 10:1915-1930
21. Tai CT, Ching CE, Lee SH,Chen YJ, Yu WC, Feng AN, Ding YA, Chang MS, Chen SA (1999) Persistent atrial flutter in patients treated for atrial fibrillation with amiodarone and propafenone: Electrophysiologic characteristics, radiofrequency catheter ablation, and risk prediction. J Cardiovasc Electrophysiol 10:1180-1187
22. Van der Berg MP, Hassink RJ, Tuinenburg AE, van Sonderen EFLP, Lefrandt JD, Kam PJ, Gelder JC, Smit AJ, Sanderman R, Crijns HJGM (2001) Quality of life in patients with paroxysmal atrial fibrillation and its predictors: importance of the autonomic nervous system. Eur Heart J 22:247-253
23. Volkmann H (2000) Atrial fibrillation - frequency control or cardioversion? Z Kardiol 10:21-27
24. Ware JE, Sherbourne CD (1992) The MOS 36-Item Short-Form Health Survey (SF-36): I. Conceptual framework and item selection. Med Car 30:473-483